Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
DVA

DVA - DaVita Inc Stock Price, Fair Value and News

$105.84+0.23 (+0.22%)
Market Closed

61/100

DVA

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

61/100

DVA

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$122.72

Target 3M

$111.58

Target 6M

$115.15

DVA Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

DVA Price Action

Last 7 days

-0.4%

Last 30 days

-6.7%

Last 90 days

-10.9%

Trailing 12 Months

-38.9%

DVA RSI Chart

DVA Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

DVA Valuation

Market Cap

7.5B

Price/Earnings (Trailing)

9.68

Price/Sales (Trailing)

0.56

EV/EBITDA

8.15

Price/Free Cashflow

5.78

DVA Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$122.72

Target 3M

$111.58

Target 6M

$115.15

DVA Fundamentals

DVA Revenue

Revenue (TTM)

13.3B

Rev. Growth (Yr)

4.8%

Rev. Growth (Qtr)

1.2%

DVA Earnings

Earnings (TTM)

771.9M

Earnings Growth (Yr)

-29.98%

Earnings Growth (Qtr)

-24.58%

DVA Profitability

EBT Margin

10.35%

Return on Equity

-134.98%

Return on Assets

4.4%

Free Cashflow Yield

17.29%

DVA Investor Care

Buy Backs (1Y)

13.90%

Diluted EPS (TTM)

9.7

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202513.0B13.2B13.3B0
202412.3B12.5B12.7B12.8B
202311.7B11.7B11.9B12.1B
202211.6B11.6B11.6B11.6B
202111.5B11.6B11.6B11.6B
202011.5B11.5B11.5B11.6B
201911.3B11.3B11.3B11.4B
201811.1B11.3B11.4B11.4B
201710.7B10.8B10.8B10.9B
201610.2B10.3B10.5B10.7B
201513.0B13.3B13.6B10.0B
201412.0B12.3B12.5B12.8B
20139.2B10.1B11.2B11.8B
20127.1B7.4B7.6B8.2B
20116.4B6.5B6.6B6.8B
20100006.4B
Get all data in R, Python etc through our Historical Stock Data APIs

About DaVita Inc

DVA
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
 CEO
 WEBSITEdavita.com
 SECTORHealthcare
 INDUSTRYMedical Care Facilities
 EMPLOYEES65535

DaVita Inc Frequently Asked Questions

DVA is the stock ticker symbol of DaVita Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of DaVita Inc is 7.47 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check DVA's fair value in chart for subscribers.

The fair value guage provides a quick view whether DVA is over valued or under valued. Whether DaVita Inc is cheap or expensive depends on the assumptions which impact DaVita Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for DVA.

As of Wed Jan 28 2026, DVA's PE ratio (Price to Earnings) is 9.68 and Price to Sales (PS) ratio is 0.56. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. DVA PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, DaVita Inc has provided 0.047 (multiply by 100 for percentage) rate of return.